Our Companies

Overview of Our Companies

BioRegenx is a health intelligence company empowering proactive healthcare and enabling a life better lived.  As a nutraceutical, dietary supplement, medical imaging device, and sales and marketing holdings company, BioRegenx is focused on growing and acquiring companies on the cutting edge of anti-aging and longevity. 

Current subsidiaries include:

1) NuLife Sciences™, Inc.

2) Microvascular Health Solutions™ LLC

3) My Body Rx™

Additionally, the company is in the process of acquiring a controlling interest in GlycoCheck™ BV.

NuLife is a research development, marketing and distribution company whose mission is to harness advanced technologies to redefine health and longevity.  We achieve this by increasing understanding of the biology that controls lifespan and anti-aging in the human body. NuLife exclusively markets the MyBodyRx™ supplement line. NuLife will also distribute GlycoCheck™, along with other products.

MVHS is a research and product development, sales, education, and marketing company that has developed the patented and clinically tested Endocalyx™ dietary supplement to improve the health of the endothelial glycocalyx. In addition, MVHS manufactures, exclusively sells and distributes the patented GlycoCheck™ software and Class 1 medical device.

My Body Rx™ is a manufacturing, sales and product development company that produces dietary supplements that complement and work synergistically with the patented and clinically tested Endocalyx™ product to support and improve healthy aging and increase longevity.

GlycoCheck™ is a research and development company dedicated to the study the endothelial glycocalyx and vascular function. GlycoCheck™ develops medical software that measures microvascular and glycocalyx function in healthy subjects and patients. In addition, GlycoCheck™ assesses and monitors the beneficial therapeutic effects of specific glycocalyx dietary supplements and pharmaceutical applications.